January 11, 2021 - Allston, MA – Elevian, Inc., today announced that it is participating in Biotech Showcase™ 2021, and providing an on-demand company presentation. This year registered attendees to Biotech Showcase can access recorded company presentations. 24x7 on-demand access allows attendees to view presentations at their convenience, avoiding conflicts with busy meeting schedules during the main event week.
Mark Allen, M.D., CEO and co-founder, will be presenting Elevian at Biotech Showcase Digital. Elevian is an emerging biopharma company developing medicines that restore youthful regenerative capacity with the potential to treat and prevent multiple age-related diseases.
“Elevian's vision is to treat multiple age-related diseases, and the aging process, by targeting the GDF11 pathway," said Dr. Allen. "We are focused now on advancing our first drug, rGDF11, toward the clinic both to promote motor function recovery following stroke. We look forward to sharing our data and plans with the Biotech Showcase attendees."
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
“We are delighted that Elevian will be presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”
ABOUT BIOTECH SHOWCASE
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year. Now in its 13th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
ABOUT ELEVIAN, INC.
Elevian is an emerging biopharma company developing medicines that restore youthful regenerative capacity, with the potential to treat and prevent multiple age-related diseases. Elevian's scientific founders, working at the Harvard Department of Stem Cell and Regenerative Biology, discovered that replenishing the circulating factor GDF11 can regenerate the heart, brain, muscle and other tissues. Elevian has acquired exclusive, worldwide rights to Harvard's patent portfolio concerning circulating factors that regulate aging. The company is developing new medicines that target the GDF11 pathway. Elevian's lead drug candidate (recombinant human GDF11) has demonstrated efficacy in preclinical models of stroke (lead program), obesity, Type 2 diabetes, heart failure, Alzheimer's disease, and many other age-related diseases.
http://www.elevian.com
